~~<i id='B2759A04B3'><strike id='B2759A04B3'><tt id='B2759A04B3'><pre id='B2759A04B3'></pre></tt></strike></i>~~

Home» explore» knowledge

knowledge

author：entertainment 2025-10-04 12:03:40 Page View：54

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New chief aims to remake Sanofi Genzyme
Next article： As demand for Covid shots wanes, Moderna seeks its next success

leisure time

In Memoriam: Notable people who died in 2023

1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

New chief aims to remake Sanofi Genzyme

NewSanofiGenzymepresidentBillSiboldisthefirstpersonwithoutanytiestoHenriTermeer(inset)toleadthecompa

In age of alternative facts, a scholarly course on calling out crap

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

2:07PoliceareinvestigatingtwoseparateattacksonwomenontheWestSideofManhattan,thattookplaceonJuly18and